Torrent Pharmaceuticals today reported 13.29 per cent decline in its consolidated net profit at Rs 163 crore for the first quarter ended June 30.
The company had posted a net profit of Rs 188 crore during the same period of the previous fiscal.
Revenue of the company, however, increased by 37 per cent during the April-June period of the current fiscal at Rs 1,872 crore as compared with Rs 1,362 crore during the same period of last year, Torrent Pharma said in a regulatory filing.
Amortisation impact of acquiring branded business of Unichem Laboratories in December 2017 and lower foreign exchange gains impacted the company's profit during the first quarter, it added.
On a standalone basis, the company posted a net profit of Rs 122 crore, up 45.23 per cent, from Rs 84 crore in the same period of 2017-18.
Shares of Torrent Pharma today ended 0.14 per cent down at Rs 1,522.70 apiece on the BSE.